MedTrace Logo

Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)

NCT00600288 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2015-01-09

No results posted yet for this study

Summary

The purpose of this pilot study is to evaluate the effect of diquafosol tetrasodium Ophthalmic Solution, 2% in dry eye subjects.

Conditions

Interventions

DRUG

diquafosol tetrasodium Ophthalmic Solution, 2%

1-2 drops administered in each eye 4 times a day for 6 weeks

DRUG

Non-preserved saline solution (Placebo)

1-2 drops administered in each eye 4 times a day for 6 weeks

Sponsors & Collaborators

Principal Investigators

  • Saiid Davari · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-05-31
Completion
2008-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600288 on ClinicalTrials.gov